Brief: Relief Therapeutics Says Olpruva Commercial Launch Progressing Ahead Of Schedule
01/05/2023 06:03
May 1 (Reuters) - Relief Therapeutics Holding SA
RLFB.S :
* RELIEF THERAPEUTICS ANNOUNCES COLLABORATION PARTNER
REPORTS
OLPRUVA™ COMMERCIAL LAUNCH PROGRESSING AHEAD OF SCHEDULE
Source text for Eikon: ID:nEQbY5J7ga
Further company coverage: RLFB.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acer Therapeutics
See all newsBrief: Leading Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Acer Therapeutics Shareholders Vote "For" The Proposed Merger And Related Proposals
U.S. STOCKS ON THE MOVE-UGI, SkyWest, Sage Therapeutics
Acer Therapeutics surges on Zevra buyout deal
Brief: Zevra Therapeutics To Acquire Acer Therapeutics, Expanding Its Rare Disease Portfolio And Adding Commercial Product
Swiss stocks - Factors to watch on August 31